In view of fundamental criteria, the company is among low performers as far as mid or long-term investment strategy is concerned.
For a short-term investment strategy, the company has poor fundamentals.
Strengths
Thanks to a sound financial situation, the firm has significant leeway for investment.
Over the last seven days, analysts have been revising upwards their EPS estimates for the company.
Weaknesses
As estimated by analysts, this group is among those businesses with the lowest growth prospects.
Low profitability weakens the company.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
The company's "enterprise value to sales" ratio is among the highest in the world.
The company is not the most generous with respect to shareholders' compensation.
The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
For the past year, analysts have significantly revised downwards their profit estimates.
Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.
The three month average target prices set by analysts do not offer high potential in comparison with the current prices.